Under COMPETE P2030, AccelBio has secured approval for Bio-Transfer: Biomedical Knowledge Commercialization Program, a joint initiative led by i3S, AccelBio, and CoLAB Trials. Bio-Transfer aims […]
Cláudia Miranda and Mariana de Araújo Branco joined HiTech 2025 with AccelBio’s project OrganTech—a cutting-edge platform using hiPSC-derived organoids to accelerate preclinical studies and help reduce Phase 1 […]
AccelBio participated in the national event “7 Years of CoLABs: Impact and Perspectives”, held at the Pavilhão do Conhecimento (Lisbon) and organized by FCoLAB. The event brought […]
The CoLAB AccelBio Connecting Day, held at Biocant Park, brought together our associates, members of the International Advisory Board (IAB), and key partners from the […]
AccelBio joined a Portuguese delegation in the EIT Health InnoStars Mission: Deep Dive into the UK Healthcare Innovation Ecosystem (28–29 April). The delegation […]
Under COMPETE P2030, AccelBio has secured approval for Bio-Transfer: Biomedical Knowledge Commercialization Program, a joint initiative led by i3S, AccelBio, and CoLAB Trials. Bio-Transfer aims […]
Cláudia Miranda and Mariana de Araújo Branco joined HiTech 2025 with AccelBio’s project OrganTech—a cutting-edge platform using hiPSC-derived organoids to accelerate preclinical studies and help reduce Phase 1 […]
AccelBio participated in the national event “7 Years of CoLABs: Impact and Perspectives”, held at the Pavilhão do Conhecimento (Lisbon) and organized by FCoLAB. The event brought […]
